- Training
- September 2023
- 3 Hours
Global
From €1451EUR$1,597USD£1,243GBP
- Training
- July 2023
- 2 Days
Global
From €1448EUR$1,593USD£1,240GBP
- Training
- 90 Minutes
Global
- Conference
- November 2025
- 1 Day
Global
€423EUR$482USD£350GBP
€483EUR$551USD£400GBP
- Conference
- October 2025
- 2 Days
Russia
€1570EUR$1,788USD£1,299GBP
€1812EUR$2,063USD£1,499GBP
- Conference
- July 2025
- 1 Day
Global
€423EUR$482USD£350GBP
€483EUR$551USD£400GBP
- Conference
- June 2025
- 2 Days
China
€1570EUR$1,788USD£1,299GBP
€1812EUR$2,063USD£1,499GBP
- Conference
- June 2025
- 2 Days
Russia
€1570EUR$1,788USD£1,299GBP
€1812EUR$2,063USD£1,499GBP
- Training
- April 2025
- 1 Day
Global
From €780EUR$859USD£668GBP
- Report
- October 2024
Italy
From €1682EUR$1,850USD£1,440GBP
- Report
- October 2024
Germany
From €1682EUR$1,850USD£1,440GBP
- Report
- October 2024
France
From €1682EUR$1,850USD£1,440GBP
- Report
- October 2024
- 70 Pages
China
From €863EUR$950USD£739GBP
- Report
- October 2024
- 70 Pages
France
From €863EUR$950USD£739GBP
- Report
- October 2024
- 70 Pages
Germany
From €863EUR$950USD£739GBP
- Report
- October 2024
- 70 Pages
India
From €863EUR$950USD£739GBP
- Training
- June 2024
- 60 Minutes
Global
- Training
- June 2024
- 90 Minutes
Global
- Report
- April 2024
- 185 Pages
Global
From €4090EUR$4,500USD£3,502GBP
- Report
- March 2024
- 51 Pages
Global
From €1091EUR$1,200USD£934GBP

The Drug Discovery market is a sector of the pharmaceutical industry that focuses on the research and development of new drugs. It involves the identification of potential drug targets, the synthesis of new compounds, and the testing of these compounds for efficacy and safety. Companies in this market use a variety of techniques, such as high-throughput screening, computer-aided drug design, and molecular modeling, to identify and develop new drugs.
The Drug Discovery market is highly competitive, with many large pharmaceutical companies and biotechnology firms competing for market share. Some of the major players in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, AstraZeneca, Sanofi, Johnson & Johnson, Bristol-Myers Squibb, and Eli Lilly. Show Less Read more